THE INFLUENCE OF SAMPLING TIME TO SERUM GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) LEVELS IN ACUTE STROKE

Neila Raisa, Hidayat Sujuti, Hari Purnomo, Masruroh Rahayu, Mochamad Dalhar
  MNJ, pp. 30-33  

Abstract


Background: Serum Glial Fibrillary Acidic Protein (GFAP) is a great potential for biomarker that is widely studied as a diagnostic biomarker of acute stroke. Sampling within 6 hours after onset is the best time window, but in Indonesia, stroke patients often arrive late more than 6 hours.
Objective: To identify the difference in time of blood sampling with serum GFAP levels within 24 hours onset of ischemic stroke (IS) patients and intracerebral hemorrhage (ICH) strokes.
Methods: Cross-sectional analysis with purposive sampling, sampling in IS and ICH strokes that arrive at the ER within 24-hour on-site. The serum GFAP examination was performed with ELISA.
Results: In this study, 41 acute stroke patients with 24-hour onset of each stroke were grouped into group 1 (<6 hours), group 2 (6-12 hours) and group 3 (12-24 hours). One Way ANOVA and Tukey's analysis showed no significant difference in GFAP levels among the three groups in both IS and ICH.
Conclusion: There was no significant difference in GFAP levels in samples <6 hours, 6-12 hours, and 12-24 hours in ischemic strokes and ICH strokes.


Keywords


GFAP; time of blood sampling; acute stroke

Full Text:

PDF

References


Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem; 2010.56(1):21–33

Wasay M, Khatri IA, Kaul S. Stroke in south asian countries. nat rev neurol; 2014.10(3):135–43. DOI: http://dx.doi.org/10.1038/nrneurol.2014.13

Raychev R, Saver JL. Mechanical thrombectomy devices for treatment of stroke. Neurol Clin Pract; 2012.2(3):231–5. DOI: 10.1212/CPJ.0b013e31826af206

Demaerschalk BM, Cheng NT, Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. The Neurohospitalist; 2015.5(3):101–9. DOI: 10.1177/1941874415583116

Wechsler LR. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue- type plasminogen activator is not firmly established. Stroke; 2014.45(3):914–5. DOI: 10.1161/STROKEAHA.113.002701

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med; 2018.378(8):708–18. DOI: 10.1056/NEJMoa1713973

Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med; 2015.372(24):2296–306. DOI: 10.1056/NEJMoa1503780

Pekny M, Hol EM. Glial fibrillary acidic protein (gfap) and the astrocyte intermediate filament system in diseases of the central nervous system. Current Opinion in Cell Biology; 2015.32:121-30. DOI: 10.1016/j.ceb.2015.02.004

Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry; 2006.77(2):181–4

Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis; 2009.27(1):37–41. DOI: 10.1159/000172632

Jiang B, Ru X, Sun H, Liu H, Sun D, Liu Y, et al. Prehospital delay and its associated factors in first-ever stroke registered in communities from three cities in china. Sci Rep; 2016.6(February):1–11. DOI: 10.1038/srep29795

Chadha V, Goel NK, Bhardwaj AK, Sharma A. Factors and decisions associated with delayed admission among stroke patients in a tertiary-care level hospital. Indian Journal of Research; 2018.7(7):113-5. Available from: https://wwjournals.com/index.php/pijr/article/view/6138/6079

Yang Z, Wang KKW. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci; 2015.38(6):364–74. DOI: http://dx.doi.org/10.1016/j.tins.2015.04.003

Tykhomyrov АA, Pavlova AS, Nedzvetsky VS. Glial fibrillary acidic protein (gfap): on the 45th anniversary of its discovery. Neurophysiology; 2016.48(1):54–71. DOI 10.1007/s11062-016-9568-8

Brunkhorst R, Pfeilschifter W, Foerch C. Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage - pathophysiological background and clinical findings. Transl Stroke Res; 2010.246–51. DOI: 10.1007/s12975-010-0040-6

Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis; 2009.37–41. DOI: 10.1159/000172632

Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol; 2006;1118–23. DOI: 10.1111/j.14681331.2006.01435.x


Refbacks

  • There are currently no refbacks.